Stock·NYSE·Industrials
AMETEK, Inc. (AME)
- Market cap
- $56.47B
- P/E
- 36.01
- Dividend yield
- 0.54%
- Street target
- $283.50median of 20 analysts
- 52-week range
- $182.87 $261.16
AME stock forecast today
Where AME stands today, and what CleaRank Financial AI makes of it.
AME at a glance
AMETEK, Inc. (AME): Buy, 70/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($243.30 and $233.67).
- Earnings AME beat estimates in 7 of the 7 reports in our data, yet fell the next day after 4 of those beats.
- Insiders Insiders sold $36.3M and bought $1.0M over the last 18 months.
- Valuation P/E of 36.0 against 34.0 for the Industrials sector: broadly in line with peers (+6%).
Figures as of October 27, 2026.
CleaRank Financial AI
AMETEK, Inc. (AME) carries a CleaRank rating of Buy and a model score of 70/100.
Trend is the strongest contributor: the price stands 5.40% above its 200-day average and 1.23% above its 50-day average, while the 50-day is 4.12% above the 200-day. Valuation is the biggest drag, with the P/S of 7.18 sitting 79.5% above the sector median. Current averages are $243.30 for the 50-day and $233.67 for the 200-day, and the price rose 31.89% over the last year.
Only on CleaRank
Figures we compute ourselves from AME's own price, earnings and insider-filing history. Tap one to see it in context.
AME stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
4/4Price above its 50-day average ›
The price of $246.30 is 1.2% above the 50-day simple moving average of $243.30.Price above its 200-day average ›
The price is 5.4% above the 200-day simple moving average of $233.67.50-day average above the 200-day ›
The 50-day average ($243.30) is 4.1% above the 200-day average ($233.67), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 81% of its 52-week range, between $182.87 and $261.16.
AME share price
Pick a period: each tab shows how far AME has moved over it, to the last close.
Today's trading
Where AME sits inside today's range and its 52-week range.
AME fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
3/5P/E below the sector median ›
The trailing P/E of 36.01 is 5.9% above the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 7.18 is 79.5% above the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $1.6B on revenue of $7.9B, a net margin of 20.0%.Beat estimates in most recent reports ›
AME beat the EPS estimate in 7 of the 7 reports in our data.Pays a dividend ›
The trailing dividend yield is 0.54%, or $1.33 a share a year.
Key statistics
The headline figures for AME.
As of October 27, 2026, AME trades at $246.30, with a market value of $56.47B, a P/E ratio of 36.01 and a dividend yield of 0.54%.
What the numbers say
CleaRank Financial AI's reading of AME's valuation, growth and risks.
AME trades on a trailing P/E of 36.01, against an Industrials median of 34.0. That makes the P/E 5.9% above the sector median P/E, and the peer comparison on this page rates it as broadly in line with peers. On sales, the P/S of 7.18 is 79.5% above the sector median of 4.0. Its market value stands at $56.5B, and trailing earnings come to $6.84 a share.
Revenue grew 15.00% in the latest quarter year on year, which is 3.3 percentage points ahead of the 11.7% median for Industrials. Profitability shows a net margin of 20.04% and an operating margin of 26.18%, with a return on equity of 14.56%, below the sector median of 17.8%. It also reports debt-to-equity of 0.21 and a trailing dividend yield of 0.54% ($1.33 a share a year).
AME's most recent quarterly report, dated August 4, 2026, showed earnings of $2.09 a share. Analysts had expected $1.99, so the company beat the estimate by 5.03%. In the first session after the report, the share price moved up 0.28%.
AME has beaten the EPS estimate in all 7 reports in our data, though the stock still fell in the first session after 4 of those 7 beats. Analysts' average EPS estimate for this fiscal year is $8.38, which would be growth of 12.7%, and $9.52 for next year (growth of 13.7%).
AME's price typically moves 1.26% on a given day, based on the 30-day standard deviation of its daily returns, and its beta against the S&P 500 is 0.96. Insiders sold $36.3M of stock over the last 18 months and bought $1.0M on the open market. Those sales are often planned in advance or made to cover tax on vesting shares, which makes them a weaker signal than purchases.
AME against the Industrials sector
How AME compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (6% difference), suggesting fair market pricing relative to industry standards.
Return vs XLI: Since May 14, 2025, AME has gained 35.4% against a gain of 18.8% for XLI.
Performance against XLI
AME and the Industrials sector fund over the same days.
Revenue and earnings
How much AME sells, and how much of it becomes profit.
Revenue growth: Revenue grew 6.6% in FY2025 to $7.4B, from $6.9B a year earlier.
Profit margin: The net margin was 20.0% in FY2025, up from 19.8% the year before.
Profitable: AME earned $1.5B in FY2025.
Earnings reality check
Did AME beat what analysts expected, and how did the stock react?
Earnings record: AME beat the analyst estimate in 7 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 4 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 4, 2026after close | $1.99 | $2.09 | +5.03% | +0.28% | +0.89% |
| Apr 30, 2026after close | $1.90 | $1.97 | +3.68% | -2.13% | -0.33% |
| Oct 30, 2025after close | $1.76 | $1.89 | +7.39% | +1.91% | -0.54% |
| Jul 31, 2025after close | $1.69 | $1.78 | +5.33% | -1.35% | -1.41% |
| May 1, 2025after close | $1.69 | $1.75 | +3.55% | +1.68% | +2.58% |
| Feb 4, 2025after close | $1.85 | $1.87 | +1.08% | -0.15% | +2.67% |
| Oct 31, 2024after close | $1.62 | $1.66 | +2.47% | -2.68% | +3.06% |
As of October 27, 2026, AME has beaten the analyst EPS estimate in 7 of the 7 reports in our data and fell in the first trading session after 4 of those beats; its latest report, on August 4, 2026, came in 5.03% above the estimate and the stock moved +0.28% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AME AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
2/2RSI not overbought or oversold ›
The 14-day RSI is 50.8, in neutral territory.RSI above 50 ›
An RSI of 50.8 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.
CleaRank Financial AI analysis of AME
The score, the reasoning behind it, and what could move the price next.
AME remains in an upward trend, with the price at $246.30. That price sits 1.23% above its 50-day average of $243.30 and 5.40% above its 200-day average of $233.67. The stock is at 81% of its 52-week range, and the price is 5.69% below the 52-week high of $261.16. Because the 50-day average is 4.12% above the 200-day average, the shorter-term trend is pulling ahead of the longer one.
The recent pullback looks smaller once it is set against the longer record. Over the past month the price fell 1.77%, but over the past three months it rose 2.02% and over the past year it rose 31.89%. The 14-day RSI sits at 50.8, which is neutral territory for momentum.
Earnings beat ›
The August 4, 2026 report beat the EPS estimate by 5.03%, and the share price rose 0.28% in the first session after it.
Source: Earnings report, August 4, 2026
Rating reaffirmed ›
Citigroup kept its Neutral rating on October 12, 2026.
Source: Analyst action, Citigroup, October 12, 2026
- The two closest levels to watch are the 52-week high at $261.16, just above the price, and the 20-day EMA at $245.95, just below it.
- A 14-day RSI of 50.8 places momentum in the neutral zone. Only readings above 70 or below 30 would signal stretched momentum.
- The share price rose 0.28% in the first session after the August 4, 2026 report. Over the 7 reports in our data, AME beat estimates in 7 of them.
AME trades above its 50-day and 200-day moving averages ($243.30 and $233.67), which is what makes the trend up; losing the 50-day would be the first warning. The nearest level under the price is the 20-day EMA at $245.95.
The next level overhead for AME is the 52-week high, at $261.16.
Technical indicators
Momentum and trend for AME, from its daily closes.
As of October 27, 2026, with AME at $246.30, its 14-day RSI is 50.8 (neutral territory), its 50-day simple moving average is $243.30 and its 200-day is $233.67.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What AME moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, AME's 1-year correlation of daily returns is +0.60 with S&P 500 (SPY), +0.55 with Nasdaq 100 (QQQ), +0.10 with Bitcoin (BTC) and +0.18 with gold (XAU).
AME price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
14 of 20 analysts rate it a buy or strong buy, 5 a hold and 1 a sell.Median target above the price ›
The median 12-month target of $283.50 is 15.1% above the price.More buy ratings than three months ago ›
14 of 20 rate it a buy now, against 14 of 20 three months ago.
AME Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 12, 2026 | Citigroup | Maintains | Neutral |
| Oct 5, 2026 | Baird | Maintains | Neutral |
| Sep 11, 2026 | BNP Paribas | Maintains | Outperform |
| Aug 6, 2026 | Truist Securities | Maintains | Buy |
| Aug 6, 2026 | TD Cowen | Maintains | Buy |
| Aug 5, 2026 | DA Davidson | Maintains | Buy |
As of October 27, 2026, 20 Wall Street analysts cover AME: 14 rate it a buy or strong buy, 5 a hold and 1 a sell or strong sell. Their 12-month price targets range from $217.00 to $318.00. The median AME price target is $283.50, 15.1% above the price of $246.30.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
AME trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
AME trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from AME's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much AME tends to move, against the market and on its own.
AME price history and drawdowns
AME's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
4/4Average daily move under 2% ›
The price has moved 1.26% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 35.1%, from January 2020 to March 2020, regained by August 2020.Most 1-year holds ended higher ›
86% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $58,698, against $42,015 in the S&P 500 (SPY).
AME Drawdowns & Recovery
As of October 27, 2026, AME's worst peak-to-trough fall over the last 10 years with dividends reinvested was -35.1% (January 2020 to March 2020); it regained that peak by August 2020, 5 months after the low, and 86% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into AME in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: AME beat the S&P 500 over this period: $58,698 against $42,015.
A $10,000 investment in AME in October 2016 would be worth about $58,698 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to AME, and which have not.
Strongest month, November: an average of +7.96%, up in 9 of 10 years.
Weakest month, March: an average of -3.01%, up in 5 of 10 years.
This month, October: has averaged +1.68%, up in 7 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, AME's strongest calendar month has been November (average +7.96%, up in 9 of 10 years) and its weakest March (average -3.01%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
AME stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in AME, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in AME today could grow to about $14,640 by 2030 in the base case, with a 90th-percentile outcome near $27,570 and a 10th-percentile outcome around $7,774. The simulation models price only; at today's 0.54% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
AME Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $361 for AME by 2030 in the base case, from $246 today (1.5x over 4 years). The 10th-percentile path ends near $191. These are outcomes of a Monte Carlo simulation run on AME's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $197 | $271 | $372 | |
| 2028 | $190 | $298 | $466 | |
| 2029 | $189 | $328 | $567 | |
| 2030 | $191 | $361 | $679 |
Method: a lognormal simulation of AME's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
AME insider trading
What the people running the company have bought and sold.
AME insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $1.0M on the open market and sold $36.3M.
As of October 27, 2026, AME insiders reported 9 open-market sales worth $36.3M and 1 open-market purchase worth $1.0M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 11, 2026 | Nickie Lee Stanage
Director
|
Buy | 4.0K | $1.0M |
| Aug 7, 2026 | David F. Hermance
Officer
|
Sell | 6.6K | $1.7M |
| Aug 7, 2026 | David F. Hermance
Officer
|
Option | 6.6K | $564.7K |
| May 7, 2026 | Nickie Lee Stanage
Director
|
Grant | 760 | $178.4K |
| Mar 24, 2026 | Thomas A Amato
Director
|
Sell | 530 | $114.9K |
| Mar 20, 2026 | Emanuela Speranza
Officer
|
Grant | 574 | - |
| Mar 18, 2026 | Thomas A Amato
Director
|
Grant | 950 | $202.1K |
| Mar 18, 2026 | Robert J. Amodei
Officer
|
Grant | 360 | $76.6K |
| Mar 18, 2026 | Tod E Carpenter
Director
|
Grant | 950 | $202.1K |
| Mar 18, 2026 | Tony J. Ciampitti
Officer
|
Grant | 1.3K | $276.6K |
| Mar 18, 2026 | Anthony James Conti
Director
|
Grant | 950 | $202.1K |
| Mar 18, 2026 | John Wesley Hardin
Officer
|
Grant | 1.4K | $289.4K |
| Mar 18, 2026 | David F. Hermance
Officer
|
Grant | 1.2K | $263.8K |
| Mar 18, 2026 | Thomas C Marecic
Officer
|
Grant | 1.2K | $263.8K |
| Mar 18, 2026 | Gretchen W Mcclain
Director
|
Grant | 950 | $202.1K |
| Mar 18, 2026 | Karleen Marie Oberton
Director
|
Grant | 950 | $202.1K |
| Mar 18, 2026 | Ronald J Oscher
Officer
|
Grant | 1.3K | $276.6K |
| Mar 18, 2026 | Dalip Puri
Chief Financial Officer
|
Grant | 3.8K | $804.3K |
| Mar 18, 2026 | Dean Seavers
Director
|
Grant | 950 | $202.1K |
| Mar 18, 2026 | Emanuela Speranza
Officer
|
Grant | 296 | - |
| Mar 18, 2026 | Suzanne L. Stefany
Director
|
Grant | 950 | $202.1K |
| Mar 18, 2026 | Nimcrut David A. Zapico
Chief Executive Officer
|
Grant | 11.9K | $2.5M |
| Feb 17, 2026 | Robert J. Amodei
Officer
|
Grant | 279 | - |
| Feb 17, 2026 | Tony J. Ciampitti
Officer
|
Grant | 2.8K | - |
| Feb 17, 2026 | John Wesley Hardin
Officer
|
Grant | 2.9K | - |
| Feb 17, 2026 | David F. Hermance
Officer
|
Grant | 2.7K | - |
| Feb 17, 2026 | Thomas C Marecic
Officer
|
Grant | 2.8K | - |
| Feb 17, 2026 | Ronald J Oscher
Officer
|
Grant | 2.8K | - |
| Feb 17, 2026 | Dalip Puri
Chief Financial Officer
|
Grant | 373 | - |
| Feb 17, 2026 | Emanuela Speranza
Officer
|
Grant | 1.4K | - |
| Feb 17, 2026 | Nimcrut David A. Zapico
Chief Executive Officer
|
Grant | 32.5K | - |
| Dec 30, 2025 | Karleen Marie Oberton
Director
|
Grant | 1.3K | - |
| Dec 26, 2025 | Thomas M. Montgomery
Officer
|
Grant | 19 | - |
| Dec 22, 2025 | Thomas M. Montgomery
Officer
|
Sell | 6.4K | $1.3M |
| Dec 22, 2025 | Thomas M. Montgomery
Officer
|
Option | 6.4K | $545.9K |
| Dec 15, 2025 | Thomas C Marecic
Officer
|
Sell | 14.3K | $2.9M |
| Dec 15, 2025 | Thomas C Marecic
Officer
|
Option | 14.3K | $906.8K |
| Dec 12, 2025 | Nimcrut David A. Zapico
Chief Executive Officer
|
Sell | 28.4K | $5.7M |
| Dec 12, 2025 | Nimcrut David A. Zapico
Chief Executive Officer
|
Grant | 31.9K | - |
| Nov 25, 2025 | Nimcrut David A. Zapico
Chief Executive Officer
|
Sell | 88.0K | $17.3M |
| Nov 25, 2025 | Nimcrut David A. Zapico
Chief Executive Officer
|
Option | 88.0K | $5.6M |
| Nov 12, 2025 | Emanuela Speranza
Officer
|
Sell | 2.7K | $540.0K |
| Oct 31, 2025 | Ronald J Oscher
Officer
|
Sell | 26.3K | $5.3M |
| Oct 31, 2025 | Ronald J Oscher
Officer
|
Option | 26.3K | $1.9M |
| Sep 11, 2025 | John Wesley Hardin
Officer
|
Sell | 7.9K | $1.5M |
Source: TwelveData, from SEC Form 4 filings
AME stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.